Hims 'able to move extremely quickly' if FDA greenlights six wellness peptides, CEO says
Hims & Hers is laying the groundwork to offer access to six banned consumer wellness peptides, should the FDA lift restrictions that prevent compounding pharmacies from making them. During its second-quarter earnings ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.